Introduction:
The United States is experiencing a rapidly increasing rate of opioid drug abuse. Intravenous drug use related endocarditis and resultant septic embolic stroke, intracranial hemorrhage and infectious intracranial aneurysm (IIAs) cause significant morbidity and mortality and have a significant impact on cost and clinical care.
Methods:
We conducted a retrospective cohort study involving patients treated for infective endocarditis (IE) at a single institution over a 54-month period between 1/1/2014 and 07/01/2018. Concomitant intravenous drug abuse and infective endocarditis was analyzed to identify and demographics, risk factors, and attributed costs.
Results:
A total of 351 patients met inclusion criteria with 170 patients (48%) having history of IVDU-associated endocarditis. From 2014 to 2018, there was a 630% increased incidence of patients with IVDU-associated endocarditis. Compared to endocarditis of other etiologies, a significant number of patients with IVDU-associated endocarditis were homeless (5.9% v 1.1%, p=0.014), uninsured (10.0% v 2.8%, p=0.005), and unemployed (75.9% v 31.7%, p=0.0001). IVDU was associated with an increased prevalence of overall intracranial hemorrhage (25.9% v 13.9%, p=0.005), including intraparenchymal hemorrhage (12.4% v 5.1%, p=0.012), subarachnoid hemorrhage (17.6 v 4.4%, p=0.0001), and cerebral microbleeds (14.1% v 7.2%, p=0.022). IVDU was also associated with an increased prevalence of IIAs (10.6% v 1.8%, p=0.0001) and brain abscesses (4.7% v 1.1%, p=0.025).
Conclusions:
The opioid epidemic has increased the incidence of infective endocarditis and resultant neurovascular complications. IVDU-associated endocarditis is associated with increased hemorrhagic stroke and increase healthcare utilization and costs.